Reshape Lifesciences Inc (24O0.BE)
| Previous close | 18.10 |
| Open | 6.38 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 6.38 - 18.10 |
| 52-week range | 6.38 - 18.10 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 05 Aug 2024 - 09 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Reshape Lifesciences Inc (RSLS) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
Despite a revenue dip, RSLS demonstrates robust cost management and strategic initiatives poised for future growth.
GlobeNewswireReShape Lifesciences® Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate Update
Commercial Launch of Next-Generation Lap-Band® 2.0 FLEX Continues Significant Reduction in Overall Operating Expenses of 51% in the First Quarter of 2024 Compared to the First Quarter of 2023 Implementation of 2024 Cost Reduction Plan Continues, Expected to Reduce Operating Expenses by 55.4% Compared to 2023 Conference Call to be Held at 4:30 pm ET Today IRVINE, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic
- GlobeNewswire
ReShape Lifesciences® to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update
Conference Call to be Held at 4:30 pm ET on Wednesday, May 15, 2024IRVINE, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that it will report its financial results for the first quarter ended March 31, 2024, including a corporate update on Wednesday, May 15, 2024, after market.Management will host a conference call on May 15 at 4:30 pm ET. A live webcast will be avail
